(Q48640667)

13 February 2018

title

Complement activation in diabetic ketoacidosis brains. (English)

1 reference

13 February 2018

main subject

diabetic ketoacidosis

1 reference

William H Hoffman

1

1 reference

13 February 2018

Cornelia D Cudrici

series ordinal

2

1 reference

13 February 2018

Ekaterina Zafranskaia

series ordinal

3

1 reference

13 February 2018

Horea Rus

series ordinal

4

1 reference

13 February 2018

publication date

21 February 2006

1 reference

13 February 2018

Experimental and Molecular Pathology

published in

1 reference

13 February 2018

volume

80

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

283-288

1 reference

13 February 2018

Molecular basis for a link between complement and the vascular complications of diabetes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The role of the complement system in ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Complement activation in the human brain after traumatic head injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Activation of microglial cells and complement following traumatic injury in rat entorhinal-hippocampal slice cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Therapeutic potential of targeting the complement cascade in critical care medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Signaling the brain in systemic inflammation: the role of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Complement activation after oxidative stress: role of the lectin complement pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

CEREBRAL LESIONS IN UNCOMPLICATED FATAL DIABETIC ACIDOSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The risk and outcome of cerebral oedema developing during diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Antioxidants effectively prevent oxidation-induced protein damage in OLN 93 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Big MAC attack: complement proteins cause leaky patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

7 January 2021

Complement and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Complement components of the innate immune system in health and disease in the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Mechanism of cerebral edema in children with diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Cytokine response to diabetic ketoacidosis and its treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The complement system as a therapeutic target in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and Type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Complement activation in diabetic ketoacidosis and its treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Complement activation in human prion disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Subclinical brain swelling in children during treatment of diabetic ketoacidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Regulation of complement activation by C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Systemic complement activation following human acute ischaemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The complement system in central nervous system diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Role of the C5b-9 complement complex in cell cycle and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The expression of complement regulatory proteins by adult human oligodendrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Electroencephalographic changes in diabetic ketosis in children with newly and previously diagnosed insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.12.007

10.1016/J.YEXMP.2005.12.007

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018